Gut microbiome and metabolic diseases

被引:102
|
作者
Fukuda, Shinji [1 ,2 ]
Ohno, Hiroshi [2 ]
机构
[1] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan
[2] RIKEN, Ctr Integrat Med Sci IMS RCAI, Lab Intestinal Ecosyst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan
基金
日本学术振兴会;
关键词
Gut microbiome; Metabolic syndrome; Obesity; Probiotics; Omics; HIGH-FAT-DIET; LACTOBACILLUS-GASSERI SBT2055; CONJUGATED LINOLEIC-ACID; GLUCAGON-LIKE PEPTIDE-1; INCREASED INTESTINAL PERMEABILITY; INDUCED OBESITY; ADIPOCYTE SIZE; BUTYRIVIBRIO-FIBRISOLVENS; AKKERMANSIA-MUCINIPHILA; BACTERIAL OVERGROWTH;
D O I
10.1007/s00281-013-0399-z
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The prevalence of obesity and obesity-related disorders is increasing worldwide. In the last decade, the gut microbiota has emerged as an important factor in the development of obesity and metabolic syndrome, through its interactions with dietary, environmental, and host genetic factors. Various studies have shown that alteration of the gut microbiota, shifting it toward increased energy harvest, is associated with an obese phenotype. However, the molecular mechanisms by which the gut microbiota affects host metabolism are still obscure. In this review, we discuss the complexity of the gut microbiota and its relationship to obesity and obesity-related diseases. Furthermore, we discuss the anti-obesity potential of probiotics and prebiotics.
引用
收藏
页码:103 / 114
页数:12
相关论文
共 50 条
  • [1] Gut microbiome and metabolic diseases
    Shinji Fukuda
    Hiroshi Ohno
    [J]. Seminars in Immunopathology, 2014, 36 : 103 - 114
  • [2] Gut microbiome, dietary lipids and metabolic diseases
    Clavel, Thomas
    [J]. CAHIERS DE NUTRITION ET DE DIETETIQUE, 2019, 54 (06): : 347 - 353
  • [3] Gut microbiome, endocrine control of gut barrier function and metabolic diseases
    Regnier, Marion
    Van Hul, Matthias
    Knauf, Claude
    Cani, Patrice D.
    [J]. JOURNAL OF ENDOCRINOLOGY, 2021, 248 (02) : R67 - R82
  • [4] The role of the gut microbiome and its metabolites in metabolic diseases
    Wu, Jiayu
    Wang, Kai
    Wang, Xuemei
    Pang, Yanli
    Jiang, Changtao
    [J]. PROTEIN & CELL, 2021, 12 (05) : 360 - 373
  • [5] The role of the gut microbiome and its metabolites in metabolic diseases
    Jiayu Wu
    Kai Wang
    Xuemei Wang
    Yanli Pang
    Changtao Jiang
    [J]. Protein & Cell., 2021, 12 (05) - 373
  • [6] Metaproteomic analysis of human gut microbiome in digestive and metabolic diseases
    Pan, Sheng
    Chen, Ru
    [J]. ADVANCES IN CLINICAL CHEMISTRY, VOL 97, 2020, 97 : 1 - 12
  • [7] Emerging connections between gut microbiome bioenergetics and chronic metabolic diseases
    Daisley, Brendan A.
    Koenig, David
    Engelbrecht, Kathleen
    Doney, Liz
    Hards, Kiel
    Al, Kait F.
    Reid, Gregor
    Burton, Jeremy P.
    [J]. CELL REPORTS, 2021, 37 (10):
  • [8] Programming of metabolic and autoimmune diseases in canine and feline: linkage to the gut microbiome
    Ji, Yun
    Yang, Ying
    Wu, Zhenlong
    [J]. MICROBIAL PATHOGENESIS, 2023, 185
  • [9] Influence of gut microbiome on metabolic diseases: a new perspective based on microgravity
    Wu, Wanxin
    Ren, Junjie
    Han, Maozhen
    Huang, Binbin
    [J]. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2024, 23 (1) : 353 - 364
  • [10] Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases
    Belizario, Jose E.
    Faintuch, Joel
    Garay-Malpartida, Miguel
    [J]. MEDIATORS OF INFLAMMATION, 2018, 2018